Log in to save to my catalogue

Using fractional exhaled nitric oxide level to diferentiate asthma-COPD overlap syndrome from chroni...

Using fractional exhaled nitric oxide level to diferentiate asthma-COPD overlap syndrome from chroni...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A623795669

Using fractional exhaled nitric oxide level to diferentiate asthma-COPD overlap syndrome from chronic obstructive pulmonary disease

About this item

Full title

Using fractional exhaled nitric oxide level to diferentiate asthma-COPD overlap syndrome from chronic obstructive pulmonary disease

Publisher

AVES

Journal title

Eurasian journal of pulmonology, 2020-01, Vol.22 (1), p.42

Language

English

Formats

Publication information

Publisher

AVES

More information

Scope and Contents

Contents

INTRODUCTION: Measurement of fractional exhaled nitric oxide (FeNO) is a simple, noninvasive, reproducible, and convenient method for assessing airway inflammation. We here assessed the value of FeNO for distinguishing asthma-COPD overlap syndrome (ACOS) and chronic obstructive pulmonary disease (COPD) in patients hospitalized due to exacerbation o...

Alternative Titles

Full title

Using fractional exhaled nitric oxide level to diferentiate asthma-COPD overlap syndrome from chronic obstructive pulmonary disease

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A623795669

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A623795669

Other Identifiers

ISSN

2148-3620

DOI

10.4103/ejop.ejop_29_19

How to access this item